ClinicalTrials.gg
CompletedNCT04049695I Can!Updated Nov 13, 2026Results posted

Improving Cognition After Cancer

An interventional study of Exercise and Control in Breast Cancer Survivors and Cognitive Dysfunction, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to female participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by University of California, San Diego · Not applicable, Interventional, and Treatment

How we know

Updated Nov 13, 2026Now CompletedResults posted+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
253
Allocation
Randomized
Ages
40 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,423 studies in Cognitive Dysfunction with a site in United States — 330 open to participants now, 432 under way, 13 of them phase 3. Cognitive Dysfunction · United States.

Enrollment
136th of 1,147
253 · median 59
Started
2019
with 88 others
No phase
716 of 1,423
182 open now
Registered
681st of 1,423
by date

Among the 1,423 studies in Cognitive Dysfunction with a site in United States, this one is the 136th largest by enrollment of the 1,147 interventional ones that give a count, is one of 89 that started in 2019, is one of 716 with no phase, and was the 681st registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

330 of the 1,423 studies in Cognitive Dysfunction with a site in United States are open now. Recruiting first, the newest first:

325 more — sign in →

All 330 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 40 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,423 studies in Cognitive Dysfunction with a site in United States, or all of them as a file.
02

Study summary

This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.

Read the detailed description

Many breast cancer survivors experience problems with mental abilities such as memory, attention, and concentration (known as cognition). Increasing physical activity has been shown to improve cognition in adults; however, little is known about whether this is helpful for cancer survivors as well. This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.

03

Conditions studied

  • Breast Cancer Survivors
  • Cognitive Dysfunction
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • breast cancer survivors who have completed active treatment at least 6 months prior to enrollment and are within 5 years of diagnosis of stage 1, 2, or 3 breast cancer
  • self-report difficulties with cognition since their cancer diagnosis
  • self-report low levels of moderate to vigorous physical activity
  • have a Fitbit compatible device with internet
  • breast cancer was treated with chemotherapy and/or hormonal therapy

Exclusion criteria

Exclusion Criteria:

  • medical condition that could make it potentially unsafe to be in an unsupervised physical activity intervention
  • currently taking tamoxifen or aromatase inhibitor that will be stopped in the next 6 months
  • unable to commit to a 12-month study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
253 participants (actual)

Study arms

  • Experimental
    Exercise Intervention

    This arm will receive a 12-month individually tailored phone and email-based exercise program.

    Behavioral: Exercise

  • Active comparator
    Health & Wellness Intervention

    This arm will receive a 12-month health and wellness program.

    Behavioral: Control

Interventions

  • BehavioralExercise

    This intervention is based on Control Theory and Social Cognitive Theory and includes: 1) weekly emails with tips and tools to set personalized exercise goals and to increase exercise; 2) Health coaching phone sessions; 3) wrist worn monitor such as a Fitbit to track activity

  • BehavioralControl

    This intervention includes: 1) weekly emails with tips and tools to support health and wellness such as brain health, stress management, nutrition; 2) Health coaching phone sessions

06

What researchers measure

Primary outcomes

  1. National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digit Test

    The NIH Toolbox Oral Symbol Digit Test is a measure of processing speed, administered on an iPad by trained staff. Participants view a key pairing nine abstract symbols with the digits 1-9 and say aloud the digit that matches each symbol in a series, completing as many items as possible in 120 seconds. Higher scores indicate faster processing speed.

    Time frame: Baseline to 6 months

Secondary outcomes

  1. National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test

    The NIH Toolbox Oral Symbol Digit Test is a measure of processing speed, administered on an iPad by trained staff. Participants view a key pairing nine abstract symbols with the digits 1-9 and say aloud the digit that matches each symbol in a series, completing as many items as possible in 120 seconds. Higher scores indicate faster processing speed.

    Time frame: Baseline to 12 months

  2. Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Abilities

    Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v2.0 - Cognitive Function - Abilities Subset, administered as a computerized adaptive test (CAT), which assesses self-perceived cognitive abilities (e.g., memory, attention, and concentration) in daily life. Raw scores are converted to T-scores, standardized to a mean of 50 and standard deviation of 10 in the U.S. general population reference sample. Higher T-scores indicate better self-reported cognitive function.

    Time frame: Baseline to 6 months and Baseline to 12 months

07

Results

Posted Nov 13, 2026

Participant flow

Participant flow — Overall Study
MilestoneExercise InterventionHealth & Wellness Intervention
Started127126
Completed119118
Not completed88

Outcome measures

PrimaryNational Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digit Test

The NIH Toolbox Oral Symbol Digit Test is a measure of processing speed, administered on an iPad by trained staff. Participants view a key pairing nine abstract symbols with the digits 1-9 and say aloud the digit that matches each symbol in a series, completing as many items as possible in 120 seconds. Higher scores indicate faster processing speed.

Time frame:
Baseline to 6 months
Reported as:
Mean · number of correct responses
National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digit Test
number of correct responsesExercise InterventionHealth & Wellness Intervention
Baseline77 ± 1.3177.2 ± 1.32
6 month81.5 ± 1.3281.5 ± 1.33
SecondaryNational Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test

The NIH Toolbox Oral Symbol Digit Test is a measure of processing speed, administered on an iPad by trained staff. Participants view a key pairing nine abstract symbols with the digits 1-9 and say aloud the digit that matches each symbol in a series, completing as many items as possible in 120 seconds. Higher scores indicate faster processing speed.

Time frame:
Baseline to 12 months
Reported as:
Mean · number of correct responses
National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test
number of correct responsesExercise InterventionHealth & Wellness Intervention
Baseline77.0 ± 1.3177.2 ± 1.32
12 month82.6 ± 1.3383.6 ± 1.33
SecondaryPatient Reported Outcomes Measurement Information System (PROMIS) Cognitive Abilities

Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v2.0 - Cognitive Function - Abilities Subset, administered as a computerized adaptive test (CAT), which assesses self-perceived cognitive abilities (e.g., memory, attention, and concentration) in daily life. Raw scores are converted to T-scores, standardized to a mean of 50 and standard deviation of 10 in the U.S. general population reference sample. Higher T-scores indicate better self-reported cognitive function.

Time frame:
Baseline to 6 months and Baseline to 12 months
Reported as:
Mean · T-score
Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Abilities
T-scoreExercise InterventionHealth & Wellness Intervention
Baseline43.9 ± 0.6843.0 ± 0.69
6 month48.1 ± 0.6947.0 ± 0.70
12 month49.9 ± 0.7048.0 ± 0.70

Adverse events

Collected over 12 month study duration. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Exercise Intervention0/127 (0%)1/127 (0.8%)13/127 (10.2%)
Health & Wellness Intervention0/126 (0%)0/126 (0%)1/126 (0.8%)
Most frequent serious events
Most frequent serious events
EventExercise InterventionHealth & Wellness Intervention
FractureMusculoskeletal and connective tissue disorders1/1270/126
Most frequent other events
Most frequent other events
EventExercise InterventionHealth & Wellness Intervention
Muscle PainMusculoskeletal and connective tissue disorders13/1271/126

Baseline characteristics

Age, Continuous
Age, Continuous(years)Exercise InterventionHealth & Wellness InterventionTotal
Mean59.29 ± 8.9957.73 ± 8.6758.51 ± 8.85
Sex: Female, Male
Sex: Female, Male(Participants)Exercise InterventionHealth & Wellness InterventionTotal
Female127126253
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Exercise InterventionHealth & Wellness InterventionTotal
American Indian or Alaska Native123
Asian121527
Native Hawaiian or Other Pacific Islander011
Black or African American448
White10193194
More than one race235
Unknown or Not Reported7815
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Exercise InterventionHealth & Wellness InterventionTotal
Hispanic or Latino212041
Not Hispanic or Latino106106212
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Exercise InterventionHealth & Wellness InterventionTotal
United States127126253
Body Mass Index (BMI)
Body Mass Index (BMI)(kg/m2)Exercise InterventionHealth & Wellness InterventionTotal
Mean29.99 ± 6.8528.77 ± 5.3629.38 ± 6.17
08

Study locations

1 site
  • Moores UCSD Cancer Center
    La Jolla, California 92093, United States
09

References and documents

Publications

  • Hartman SJ, Shao LY, Zablocki RW, Natarajan L, Ahles T, Palmer BW, Sears DD, Tam RM, Mac V, Dillon L, Yan C, Parker BA. Effectiveness of an exercise intervention on cognition in breast cancer survivors: a randomized controlled trial. J Natl Cancer Inst. 2026 Sep 30:djag295. doi: 10.1093/jnci/djag295. Online ahead of print. PubMed 42810736 ↗
  • Carlin D, Ott O, Sears DD, Ahles T, Desplats P, Hartman SJ. Exercise slows biological aging in breast cancer survivors: secondary analysis of a randomized trial. J Natl Cancer Inst. 2026 Sep 30:djag296. doi: 10.1093/jnci/djag296. Online ahead of print. PubMed 42810733 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2019 to primary completion in Jan 2024, 52 months.

Results were first posted in Nov 2026, 2 years 9 months after primary completion.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 52 months is above that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

Completion moved once since we started tracking on Sep 25, 2026: Feb 2025 → Oct 2025, on Nov 13, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 6, 2019
First posted
Aug 8, 2019
StartActual
Sep 9, 2019
Primary completionActual
Jan 19, 2024
CompletionActual
Oct 15, 2025was Feb 2025
Results first posted
Nov 13, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 13, 2026
Results
Results posted
posted Nov 13, 2026
Study completion
Feb 1, 2025→Oct 15, 2025 (actual)
Nov 13, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedNational Institutes of Health Toolbox - Cognition Domain - Oral Symbol DigitalDigit TestTime frame: Baseline to 6 months
Nov 13, 2026
Documents
Publications
2 publications citing this study linked from PubMed, e.g. PubMed 42810736 ↗
Nov 13, 2026
Secondary outcomes
1 edited, 1 description edited
What changed in the outcomes
  • EditedPatient Reported Outcomes Measurement Information System (PROMIS) cognitive abilitiesCognitive AbilitiesTime frame: Baseline to 6 months and Baseline to 12 months
  • DescriptionNational Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test: how it is measured was reworded
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Active, not recruiting→Completed
    Results posted
    Publications 2 publications citing this study linked from PubMed, e.g. PubMed 42810736 ↗
    Study completion Feb 1, 2025→Oct 15, 2025 (now actual)
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedNational Institutes of Health Toolbox - Cognition Domain - Oral Symbol DigitalDigit TestTime frame: Baseline to 6 months
    Secondary outcomes 1 edited, 1 description edited
    What changed in the outcomes
    • EditedPatient Reported Outcomes Measurement Information System (PROMIS) cognitive abilitiesCognitive AbilitiesTime frame: Baseline to 6 months and Baseline to 12 months
    • DescriptionNational Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test: how it is measured was reworded
    + 3 other changes: identifiers, verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04049695
Responsible party
Sheri Hartman (Professor, University of California, San Diego) — Principal investigator
First posted
Aug 8, 2019
Start date
Sep 9, 2019
Primary completion
Jan 19, 2024
Completion
Oct 15, 2025
Results posted
Nov 13, 2026
Last update
Nov 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion